Literature DB >> 15106084

Evolution of measles elimination strategies in the United States.

Alan R Hinman1, Walter A Orenstein, Mark J Papania.   

Abstract

There have been 3 efforts to eliminate measles from the United States since the introduction of measles vaccine in 1963. To date, 10 major lessons have been learned from elimination efforts. First, elimination requires very high vaccination-coverage levels by age 2 years. Second, school immunization requirements ensure high coverage rates among schoolchildren. Third, a second dose of measles vaccine is needed to achieve satisfactory levels of immunity. Fourth, school immunization requirements can also ensure delivery of a second dose. Fifth, coverage assessment is crucial. Sixth, measles surveillance is critical for developing, evaluating, and refining elimination strategies. Seventh, surveillance requires laboratory backup to confirm a diagnosis. Eighth, tracking measles virus genotypes is critical to determining if an endemic strain is circulating. Ninth, once endemic transmission has been interrupted, internationally imported measles cases will continue and will cause small outbreaks. Tenth, collaborative efforts with other countries are essential to reduce imported measles cases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15106084     DOI: 10.1086/377694

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  The Reemergence of Measles.

Authors:  C L Abad; N Safdar
Journal:  Curr Infect Dis Rep       Date:  2015-12       Impact factor: 3.725

2.  An assessment of measles vaccine effectiveness, Australia, 2006-2012.

Authors:  Alexis Pillsbury; Helen Quinn
Journal:  Western Pac Surveill Response J       Date:  2015-07-09

3.  Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation.

Authors:  Ole Wichmann; Anette Siedler; Daniel Sagebiel; Wiebke Hellenbrand; Sabine Santibanez; Annette Mankertz; Georg Vogt; Ulrich van Treeck; Gérard Krause
Journal:  Bull World Health Organ       Date:  2009-02       Impact factor: 9.408

4.  Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality.

Authors:  Michael J Mina; C Jessica E Metcalf; Rik L de Swart; A D M E Osterhaus; Bryan T Grenfell
Journal:  Science       Date:  2015-05-07       Impact factor: 47.728

5.  Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.

Authors:  Chao Ma; Fangjun Li; Xiang Zheng; Hong Zhang; Mengjuan Duan; Yanhua Yang; Lixin Hao; Qiru Su; Lance Rodewald; Bosong Guo; Shanliang Xiao; Huaqing Wang; Li Li; Junhua Li; Huiming Luo; Lidong Gao
Journal:  BMC Infect Dis       Date:  2015-01-22       Impact factor: 3.090

6.  Monitoring progress towards the elimination of measles in China: an analysis of measles surveillance data.

Authors:  Chao Ma; Lixin Hao; Yan Zhang; Qiru Su; Lance Rodewald; Zhijie An; Wenzhou Yu; Jing Ma; Ning Wen; Huiling Wang; Xiaofeng Liang; Huaqing Wang; Weizhong Yang; Li Li; Huiming Luo
Journal:  Bull World Health Organ       Date:  2014-02-05       Impact factor: 9.408

7.  Improving the Science of Measles Prevention-Will It Make for a Better Immunization Program?

Authors:  Julie Garon; Walter Orenstein
Journal:  PLoS Med       Date:  2016-10-11       Impact factor: 11.069

8.  A Case of Early Onset Subacute Sclerosing Panencephalitis Presented as Juvenile Myoclonic Epilepsy.

Authors:  Ranjan Bhattacharyya; Bhaskar Mukherjee; Sumita Bhattacharyya
Journal:  Indian J Psychol Med       Date:  2017 Nov-Dec

Review 9.  Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges.

Authors:  Nicholas Israel Nii-Trebi
Journal:  Biomed Res Int       Date:  2017-02-13       Impact factor: 3.411

10.  Challenges in Establishing Vaccine Induced Herd Immunity through Age Specific Community Vaccinations.

Authors:  Barsha Dassarma; Satyajit Tripathy; Matimbha Chabalala; Motlalepula Gilbert Matsabisa
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.